Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BactiQuant ASOCSE:BACTIQ 54 Debt-to-Equity is 0.50 as of Dec. 2025, which is 100% above its 10-year median of 0.25. GuruFocus rates OCSE:BACTIQ with a GF Score™ of 54/100 and a GF Value™ of kr2.30 (Fairly Valued). The stock has 4 warning signs investors should review. Among 2,681 Industrial Products companies, BactiQuant AS ranks worse than 68% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for BactiQuant AS's Debt-to-Equity or its related term are showing as below:
OCSE:BACTIQ'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.05 Med: 0.25 Max: 16.35
Current: 0.5
During the past 8 years, the highest Debt-to-Equity Ratio of BactiQuant AS was 16.35. The lowest was 0.05. And the median was 0.25.
OCSE:BACTIQ's Debt-to-Equity is ranked worse than 68% of 2681
companies
in the Industrial Products industry
Industry Median: 0.28
vs OCSE:BACTIQ: 0.50
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
BactiQuant AS Debt-to-Equity Related Terms
BactiQuant AS Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for BactiQuant AS's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:BACTIQ vs VLTO, ZWS, CECO: Debt-to-Equity Comparison
For the Pollution & Treatment Controls subindustry, BactiQuant AS's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BactiQuant AS Debt-to-Equity vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, BactiQuant AS's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where BactiQuant AS's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BactiQuant AS (OCSE:BACTIQ) has a Debt-to-Equity of 0.50 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on BactiQuant AS and its competitors. This is 100% above median its historical median of 0.25. Over the past decade, BactiQuant AS's Debt-to-Equity has ranged from 0.05 to 16.35. According to the industry distribution chart, BactiQuant AS ranks #1823 out of 2681 companies in the Industrial Products industry, placing it in the top 68%.
Is BactiQuant AS's Debt-to-Equity too high?
BactiQuant AS's current Debt-to-Equity of 0.50 is 100% above median its 10-year median of 0.25. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 16.35. The Industrial Products industry median Debt-to-Equity is 0.28. BactiQuant AS's value of 0.50 is 78.6% above this industry median. Based on the distribution chart, BactiQuant AS ranks #1823 out of 2681 companies in the Industrial Products industry, which is below the industry midpoint. Overall, BactiQuant AS has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BactiQuant AS's Debt-to-Equity compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, BactiQuant AS ranks #1823 out of 2681 companies for Debt-to-Equity. This places BactiQuant AS in the lower half of its industry. The industry median Debt-to-Equity is 0.28. BactiQuant AS's value of 0.50 is 78.6% above this benchmark. Historically, BactiQuant AS's own Debt-to-Equity has ranged from 0.05 to 16.35 over the past decade. While the company's 10-year median is 0.25 vs. the industry median of 0.28, BactiQuant AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for an Industrial Products company?
The median Debt-to-Equity among Industrial Products companies is 0.28, based on 2,681 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BactiQuant AS's current Debt-to-Equity of 0.50 is 78.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on BactiQuant AS and its competitors. For the Industrial Products industry, the median Debt-to-Equity is 0.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BactiQuant AS's current Debt-to-Equity is 0.50, which is 100% above median its own 10-year median of 0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BactiQuant AS stock overvalued right now?
Based on GuruFocus' analysis, BactiQuant AS (OCSE:BACTIQ) is currently considered Fairly Valued. The stock's GF Value™ is kr2.30, compared to a current price of kr2.26 — trading 1.7% below its estimated fair value. The current Debt-to-Equity is 0.50, which is 100% above median its 10-year median of 0.25 and 78.6% above the Industrial Products industry median of 0.28. BactiQuant AS's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For BactiQuant AS (OCSE:BACTIQ), the current Debt-to-Equity is 0.50 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BactiQuant AS (OCSE:BACTIQ) Overvalued in 2026?
Based on GuruFocus' analysis, BactiQuant AS stock appears to be undervalued.
The current stock price of kr2.26 is trading 1.7% below its estimated GF Value™ of kr2.30.
GuruFocus considers BactiQuant AS to be Fairly Valued.
Key valuation signals for OCSE:BACTIQ:
Debt-to-Equity: 0.50 (100% above median its 10-year median of 0.25)
GF Value™: kr2.30 vs. price of kr2.26 (1.7% below fair value)
Industry Position: 78.6% above the Industrial Products median (#1823 of 2681)
No single metric tells the full story. See the OCSE:BACTIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. Its segments are Aquaculture, Data Centres, Oil & Gas, Water Utility, Industry, and Pharma. The group's products are BQ Online 2.0 PRO, BQ Online, BQ Mobile Lab, and Analysis Kits.
54GF Score
Get the complete analysis for OCSE:BACTIQ
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:BACTIQ has been successfully added to your 
